SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-11-019382
Filing Date
2011-04-11
Accepted
2011-04-11 07:31:06
Documents
7
Period of Report
2011-05-26
Effectiveness Date
2011-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A a11-7480_1def14a.htm DEF 14A 1402141
3 GRAPHIC g74801be01i001.jpg GRAPHIC 4266
4 GRAPHIC g74802bgi001.gif GRAPHIC 110980
5 GRAPHIC g74802bgi002.gif GRAPHIC 58348
6 GRAPHIC g74801be03i001.jpg GRAPHIC 4266
7 GRAPHIC g74801bci001.jpg GRAPHIC 3880
8 GRAPHIC g74801be05i001.jpg GRAPHIC 4266
  Complete submission text file 0001104659-11-019382.txt   1660464
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 11751565
SIC: 2836 Biological Products, (No Diagnostic Substances)